Correction to: NHF-derived carbon dots: prevalidation approach in breast cancer treatment
Crina Elena Tiron, Gabriel Luta, Mihail Butura, Florin Zugun‑Eloae, Corneliu S. Stan, Adina Coroaba, Elena‑Laura Ursu, Gabriela Dumitrita Stanciu, Adrian Tiron
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCarbon and Quantum Dots Applications · Nanocluster Synthesis and Applications · Nanoplatforms for cancer theranostics
Correction to: Scientific Reports 10.1038/s41598-020-69670-z, published online 29 July 2020
The original Article contains an error in Figure 2. During the preparation of Figure 2b the image for the condition “4T1_HUVEC_PASMCs_CD-NHF 5%” was erroneously duplicated from the condition “4T1_CD-NHF-5%” in Figure 2a.Fig. 2. Effect of CD-NHF in 3D matrigel assay. A Monoculture.a,b MDA-MB-231 (a-untreated, b-treated); c,d 4T1 (c-untreated, d-treated); e,f MCF7 (e-untreated, f-treated); B. Co-culture a,b MDA-MB-231 (a-untreated, b-treated); c,d 4T1 (c-untreated, d-treated); e,f MCF7 (e-untreated, f-treated). 10 ×, N = 3 matrigels/experiment. Pictures acquired at 10 ×.
The correct Figure 2 and accompanying legend appear below.